Clinical trial sponsors are experiencing first-hand how critical it is to have flexible solutions to mitigate the challenges created by the COVID-19 pandemic. These solutions will continue to be relevant throughout the pandemic and thereafter. 

This paper will discuss why now is the time for sponsors to evaluate and determine if adopting virtual trial solutions will have a beneficial impact on the challenges of running dermatology trials now and in the future.